Katipunan, Genesis G.

HRN: 22-25-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2022
CEFUROXIME 1.5GM (VIAL)
11/26/2022
12/03/2022
IV
1.5g
Q8
Open Fracture 3A
Waiting Final Action 
11/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/26/2022
12/03/2022
IV
600mg
Q6
Open Fracture 3A
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: